(Q33879213)

29 July 2017

Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective study (English)

1 reference

dementia with Lewy bodies

29 July 2017

0 references

1 reference

1 reference

5

Dag Aarsland

1 reference

29 July 2017

6

Elisabet Londos

1 reference

29 July 2017

4

Lennart Minthon

1 reference

29 July 2017

3

Clive Ballard

1 reference

29 July 2017

1

Kajsa Stubendorff

1 reference

29 July 2017

2

Victoria Larsson

1 reference

29 July 2017

3 July 2014

1 reference

29 July 2017

1 reference

29 July 2017

4

1 reference

29 July 2017

7

1 reference

29 July 2017

e005158

1 reference

The impact of autonomic dysfunction on survival in patients with dementia with Lewy bodies and Parkinson's disease with dementia

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Treatment of dementia with Lewy bodies and Parkinson's disease dementia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Rapidly progressive diffuse Lewy body disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Eligibility of Alzheimer's disease clinic patients for clinical trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Amantadine treatment is an independent predictor of improved survival in Parkinson's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4091277

Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions

5 July 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005158

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005158

Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005158

The effect of memantine on sleep behaviour in dementia with Lewy bodies and Parkinson's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005158

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005158

Cerebrospinal fluid total tau is associated with shorter survival in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005158

Survival in a population-based cohort of dementia patients: predictors and causes of mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005158

The 'natural' endpoint of dementia: death from cachexia or dehydration following palliative care?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBMJOPEN-2014-005158

Predictors of survival in dementia with lewy bodies and Parkinson dementia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24993765

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Participation in clinical trials and long-term outcomes in Alzheimer's disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24993765

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJOPEN-2014-005158

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

24993765